Dianthus Therapeutics, Inc. (DNTH)
NASDAQ: DNTH · Real-Time Price · USD
108.10
+0.25 (0.23%)
At close: Sep 4, 2026, 4:00 PM EDT
108.11
+0.01 (0.01%)
After-hours: Sep 4, 2026, 7:58 PM EDT
Dianthus Therapeutics Market Cap
Dianthus Therapeutics has a market cap or net worth of $6.05 billion as of September 4, 2026. Its market cap has increased by 674.31% in one year.
Market Cap
6.05B
Enterprise Value
4.86B
1-Year Change
674.31%
Ranking
Category
Stock Price
$108.10
ChartMarket Cap Chart
Since September 12, 2023, Dianthus Therapeutics's market cap has increased from $162.99M to $6.05B, an increase of 3,609.63%. That is a compound annual growth rate of 236.11%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 4, 2026 | 6.05B | 242.21% |
| Dec 31, 2025 | 1.77B | 173.85% |
| Dec 31, 2024 | 645.21M | 318.69% |
| Dec 29, 2023 | 154.10M | -5.45% |
| Sep 12, 2023 | 162.99M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scholar Rock Holding | 6.74B |
| CG Oncology | 6.62B |
| Mirum Pharmaceuticals | 6.55B |
| Travere Therapeutics | 6.15B |
| Oruka Therapeutics | 6.13B |
| Cogent Biosciences | 6.03B |
| Xenon Pharmaceuticals | 5.79B |
| PTC Therapeutics | 5.78B |